| | | CASTALIN
CAS:19086-75-0
Trade Name: 7,8,9,12,13,14,17,18,19,25,29-undecahydroxy-24-(hydroxymethyl)-3,23,26-trioxahexacyclo[13.10.3.12,6.
Formula: C27H20O18
FFC-AR-19086750
632.44 CASTASTERONE
CAS:80736-41-0
Formula: C28H48O5
ACM80736410
464.67772
(22R,23R,24S)-2+¦,3+¦,22,23-Tetrahydroxy-24-methyl-5+¦-cholestan-6-one;(22R,23R,24S)-2+¦,3+¦,22,23-Tetrahydroxy-5+¦-ergostane-6-one;(2+¦,3+¦,5+¦,22R,23R,24S)-2,3,22,23-Tetrahydroxyergostan-6-one;BP 214 CASTOROIL, SULFATED, SODIUM SALT
CAS:68187-76-8
ACM68187768
MONOPOLOEL 100/23;Rizinusl, sulfatiert, Natriumsalz;Castor oil sodium sulfate;(Hydrolysis products of sulfated castor oil), sodium salts;Castor oil, sulfate, sodium salt;Castor oil, sulfated sodium salts;Castor oil, sulfated, sodium salts;E CATALPOL
CAS:2415-24-9
Trade Name: (2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]d
Formula: C15H22O10
BBC2415249
362.33
1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl CATALPOL
CAS:2415-24-9
Trade Name: (2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]d
Formula: C15H22O10
FFC-AR-2415249
362.33
1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl CATALPOL
CAS:2415-24-9
Trade Name: (2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]d
Formula: C15H22O10
ACM2415249
362.33
1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl CATALPOL
CAS:2415-24-9
Trade Name: (2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]d
Formula: C15H22O10
ACM2415249
362.33
1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl CATENARIN
CAS:476-46-0
Formula: C15H10O6
ACM476460
286.24
1,4,6,8-TETRAHYDROXY-3-METHYLANTHRAQUINONE;CATENARIN;1,4,5,7-tetrahydroxy-2-methyl-anthraquinon;1,4,5,7-tetrahydroxy-2-methylanthraquinone;2-methyl-1,4,5,7-tetrahydroxy-10-anthracenedione;caterarin;4-HYDROXYEMODIN;1,4,5,7-Tetrahydroxy-2-met CATHARANTHINE
CAS:2468-21-5
Formula: C21H24N2O2
APS2468215
336.43
Catharanthine, (+)-, Catharanthine (6CI,7CI,8CI), (+)-Catharanthine, (+)-3,4-Didehydrocoronaridine, 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine-18-carboxylic acid deriv., Catharanthin,Ibogamine-18-carboxylic acid, 3,4-di CATHARANTHINE SULFATE
CAS:70674-90-7
Trade Name: methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-p
Formula: C21H26N2O6S
ACM70674907-1
434.51 g/mol
CATHARANTHINE SULFATE;Catharanthine sulfate, >=98% CATHARANTHINE SULFATE
CAS:70674-90-7
Trade Name: methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-p
Formula: C21H26N2O6S
ACM70674907
434.51
CATHARANTHINE SULFATE;Catharanthine sulfate, >=98% CATHARANTHINE SULFATE
CAS:70674-90-7
Trade Name: methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-p
Formula: C21H26N2O6S
BBC70674907
434.51
CATHARANTHINE SULFATE;Catharanthine sulfate, >=98% CATHARTICIN
CAS:39723-40-5
Trade Name: 3-[(2S,3R,4S,5R,6R)-6-[[(2R,3R,4R,5S,6S)-3,5-dihydroxy-6-methyl-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy
Formula: C34H42O19
ACM39723405
754.69 Cathepsin C Protein, Human, Recombinant (His)
RHC-ENZY-1930
51 kDa (predicted); 55 kDa (reducing conditions)
PLS, PDON1, PALS, JPD, JP, HMS, DPP-I, DPPI, DPP1, CPPI, cathepsin C Cationic trypsin Protein, Canine, Recombinant (His & SUMO)
RHC-ENZY-2244
39.6 kDa (predicted)
TRYP1, TRY1, TRP1, Serine protease 1, PRSS1, Pretrypsinogen I, Cationic trypsinogen, Beta-trypsin, Anionic trypsin-1, Anionic trypsin I CAUDATIN
CAS:38395-02-7
Trade Name: [(3S,8S,9R,10R,12R,13S,14R,17R)-17-acetyl-3,8,14,17-tetrahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15
Formula: C28H42O7
BBC38395027
490.63
(3beta,12beta,14beta,17alpha)-12-[[(2E)-3,4-Dimethyl-1-oxo-2-pentenyl]oxy]-3,8,14,17-tetrahydroxypregn-5-en-20-one CAULOPHYLLOGENIN
CAS:52936-64-8
Trade Name: (4aR,5R,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-5,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethy
Formula: C30H48O5
ACM52936648
488.7
3BETA, 16ALPHA, 23-TRIHYDROXYOLEAN-12-ENE 28-OIC ACID;3BETA,16ALPHA,23-TRIHYDROXYYOLEAN-12-ENE 28-OIC-ACID;CAULOPHYLLOGENIN;(3beta,4alpha,16alpha)-3,16,23-trihydroxyolean-12-en-28-oic acid;CAULOPHYLLOGENIN hplc;CAULOPHYLLOGENIN WITH HPLC;(4 CAULOPHYLLOGENIN
CAS:52936-64-8
Trade Name: (4aR,5R,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-5,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethy
Formula: C30H48O5
ACM52936648
488.7
3BETA, 16ALPHA, 23-TRIHYDROXYOLEAN-12-ENE 28-OIC ACID;3BETA,16ALPHA,23-TRIHYDROXYYOLEAN-12-ENE 28-OIC-ACID;CAULOPHYLLOGENIN;(3beta,4alpha,16alpha)-3,16,23-trihydroxyolean-12-en-28-oic acid;CAULOPHYLLOGENIN hplc;CAULOPHYLLOGENIN WITH HPLC;(4 CAULOPHYLLOGENIN
CAS:52936-64-8
Trade Name: (4aR,5R,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-5,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethy
Formula: C30H48O5
FFC-AR-52936648
488.7
(3+¦,4+¦,16+¦)-3,16,23-Trihydroxyolean-12-en-28-oic acid CAULOSIDE A
CAS:17184-21-3
Trade Name: (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2S,3R,4S,5S
Formula: C35H56O8
ACM17184213
604.81 CAULOSIDE A
CAS:17184-21-3
Trade Name: (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2S,3R,4S,5S
Formula: C35H56O8
ACM17184213
604.81 CAULOSIDE F
CAS:60451-47-0
Trade Name: [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-
Formula: C59H96O27
ACM60451470
1237.4 Caulosidec(p)(new)
CAS:20853-58-1
Trade Name: (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy
Formula: C41H66O13
ACM20853581
766.96
Cauloside C, CID159898, 20853-58-1, 3-((2-0-beta-D-Glucopyranosyl-alpha-L-arabinopyranosyl)oxy)-23-hydroxyolean-12-en-28-oic acid CAY10578
CAS:19231-60-8
Trade Name: N,N-(tetraiodo-phthaloyl)-glycine
Formula: C10H3I4NO4
ACM19231608
708.75300
1,4,5,6-tetrahydro-pyrimidine; 3,4,5,6-Tetraiod-phthalimidoessigsaeure; tetrahydro-pyrimidine; 1,4,5,6-Tetrahydro-pyrimdin; Tetraiodphthalimidoessigsaeure; 1H-1,4,5,6-tetrahydropyrimidine; 1,4,5,6-Tetrahydro-pyrimidin; 3,4,5,6-tetrahydropyr CAY10595
CAS:916047-16-0
Trade Name: 2-[5-chloro-1-[(5-chloro-2-fluorophenyl)methyl]-2,2,5-trioxospiro[indole-3,3-pyrrolidine]-1-yl]aceti
Formula: C20H13Cl2FN2O5
ACM916047160
451.232023 [g/mol]
CAY10595, 916047-16-0, AGN-PC-00QB8R, SureCN2483463, Spiro-indolinone analogue, 71, CHEMBL258965, CTK8F0801, MolPort-009-019-539, 2-[5-chloro-1-[(5-chloro-2-fluorophenyl)methyl]-2,2,5-trioxospiro[indole-3,3-pyrrolidine]-1-yl]acetic acid CBP, 4,4'-Bis(N-carbazolyl)-1,1'-biphenyl
CAS:58328-31-7
Trade Name: 9-[4-(4-carbazol-9-ylphenyl)phenyl]carbazole
Formula: C36H24N2
ACM58328317-6
484.59 g/mol
CBP, 4,4'-Bis(9-carbazolyl)-1,1'-biphenyl, 4,4-N,N'-Dicarbazole-1,1'-biphenyl,DCBP, BSBCz, BSB-Cz CBR1 Protein, Human, Recombinant (E. coli, His)
RHC-ENZY-0195
34.2 kDa (predicted)
SDR21C1, Prostaglandin 9-ketoreductase, PG-9-KR, NADPH-dependent carbonyl reductase 1, CRN, CBR1, CBR, Carbonyl reductase [NADPH] 1, Alcohol dehydrogenase [NAD(P)+] CBR1, 20-beta-hydroxysteroid dehydrogenase, 15-hydroxyprostaglandin dehydro CBR1 Protein, Human, Recombinant (His)
RHC-ENZY-0229
32.2 kDa (predicted)
SDR21C1, Prostaglandin 9-ketoreductase, PG-9-KR, NADPH-dependent carbonyl reductase 1, CRN, CBR1, CBR, Carbonyl reductase [NADPH] 1, Alcohol dehydrogenase [NAD(P)+] CBR1, 20-beta-hydroxysteroid dehydrogenase, 15-hydroxyprostaglandin dehydro CBZ-4-IODO-L-PHENYLALANINE
CAS:220400-04-4
Trade Name: (2S)-3-(4-iodophenyl)-2-(phenylmethoxycarbonylamino)propanoic acid
Formula: C17H16INO4
ACM220400044
425.23
(S)-2-(((Benzyloxy)carbonyl)amino)-3-(4-iodophenyl)propanoic acid, 220400-04-4, SureCN7469563, Cbz-4-Iodo-L-Phenylalanine, CTK8B7660, MolPort-003-990-246, ANW-58097, AKOS016003075, AK-88087, KB-48788, KB-210845, (2S)-2-{[(benzyloxy)carbonyl CCBL2 Protein, Human, Recombinant (His & SUMO)
RHC-ENZY-0561
67.4 kDa (predicted)
Kynurenine--oxoglutarate transaminase III, Kynurenine--oxoglutarate transaminase 3, Kynurenine--glyoxylate transaminase, Kynurenine aminotransferase III, Kynurenine aminotransferase 3, KYAT3, KATIII, KAT3, Cysteine-S-conjugate beta-lyase 2, CCL14 Protein, Human, Recombinant (aa 28-93, His)
RHC-CGF-0448
9.3 kDa (predicted); 12 kDa (reducing conditions)
SY14, SCYL2, SCYA14, NCC-2, NCC2, MCIF, HCC-3, HCC-1/HCC-3, HCC-1(1-74), HCC-1, FLJ16015, CKB1, chemokine (C-C motif) ligand 14, CC-3, CC-1 CCL14 Protein, Human, Recombinant (His)
RHC-CGF-0490
10.2 kDa (predicted); 12 kDa (reducing conditions)
SY14, SCYL2, SCYA14, NCC-2, NCC2, MCIF, HCC-3, HCC-1/HCC-3, HCC-1(1-74), HCC-1, FLJ16015, CKB1, chemokine (C-C motif) ligand 14, CC-3, CC-1 CCL16 Protein, Human, Recombinant
RHC-CGF-0560
14 kDa (reducing condition)
Small-Inducible Cytokine A16, SCYA16, NCC-4, NCC4, MTN-1, Monotactin-1, Lymphocyte and Monocyte Chemoattractant, LMC, Liver-Expressed Chemokine, LCC-1, ILINCK, IL-10-Inducible Chemokine, HCC-4, Chemokine LEC, Chemokine CC-4, CCL16, C-C Moti CCL16 Protein, Human, Recombinant (His)
RHC-CGF-0551
13.3 kDa (predicted); 15 kDa (reducing conditions)
SCYL4, SCYA16, NCC-4, NCC4, Mtn-1, LMC, LEC, LCC-1, ILINCK, HCC-4, CKb12, chemokine (C-C motif) ligand 16, CCL16 CCL18 Protein, Human, Recombinant (His)
RHC-CGF-0437
9.2 kDa (predicted); 9 kDa (reducing conditions)
SCYA18, PARC, MIP-4, MIP4, DC-CK1, DCCK1, CKb7, chemokine (C-C motif) ligand 18, CCL18, AMAC-1, AMAC1 CCL2 Protein, Human, Recombinant
RHC-CGF-0444
13 kDa (reducing condition)
Small-inducible cytokine A2, Monocyte secretory protein JE, Monocyte chemotactic protein 1, Monocyte chemotactic and activating factor, Monocyte chemoattractant protein 1, MCP-1, MCAF, HC11, CCL2, C-C motif chemokine 2 CCL2 Protein, Mouse, Recombinant
RHC-CGF-0431
12 kDa (reducing condition)
Small-inducible cytokine A2, Scya2, Platelet-derived growth factor-inducible protein JE, Monocyte chemotactic protein 1, Monocyte chemoattractant protein 1, MCP-1, Mcp1, Je, Ccl2, C-C motif chemokine 2 CCL20 Protein, Human, Recombinant (His)
RHC-CGF-0419
10.2 kDa (predicted); 10 kDa (reducing conditions)
ST38, SCYA20, MIP-3-+¦, MIP-3-alpha, MIP-3a, MIP3A, LARC, Exodus, CKb4, chemokine (C-C motif) ligand 20 CCL20 Protein, Mouse, Recombinant
RHC-CGF-0467
8.1 kDa (predicted)
ST38, Scya20, MIP-3A, MIP3A, MIP-3[a], LARC, exodus-1, CKb4, chemokine (C-C motif) ligand 20 CCL20 Protein, Mouse, Recombinant (His)
RHC-CGF-0529
9.3 kDa (predicted); 14 kDa (reducing conditions)
ST38, Scya20, MIP-3A, MIP3A, MIP-3[a], LARC, exodus-1, CKb4, chemokine (C-C motif) ligand 20 CCL21 Protein, Human, Recombinant
RHC-CGF-0573
12.3 kDa (predicted); 18 kDa (reducing conditions)
TCA4, SLC, SCYA21, RP11-195F19.22-001, MGC34555, ECL, CKb9, chemokine (C-C motif) ligand 21, 6Ckine CCL21a Protein, Mouse, Recombinant
RHC-CGF-0411
12.1 kDa (predicted)
Tca4, SLC, Scya21b, SCYA21a, Scya21, plt, CKb9, chemokine (C-C motif) ligand 21A (serine), ALP, 6Ckine, 6CKBAC2 CCL21a Protein, Mouse, Recombinant (His)
RHC-CGF-0574
13.5 kDa (predicted)
Tca4, SLC, Scya21b, SCYA21a, Scya21, plt, CKb9, chemokine (C-C motif) ligand 21A (serine), ALP, 6Ckine, 6CKBAC2 CCL24 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0561
12.36 kDa (predicted). Due to glycosylation, the p
SCYA24, MPIF-2, MPIF2, member 24, Eotaxin-2, CK-+¦-6, CK-beta-6, Ckb-6, CCL24 CCL24 Protein, Human, Recombinant (hFc)
RHC-CGF-0563
36.5 kDa (predicted). Due to glycosylation, the pr
SCYA24, MPIF-2, MPIF2, member 24, Eotaxin-2, CK-+¦-6, CK-beta-6, Ckb-6, CCL24 CCL24 Protein, Mouse, Recombinant (hFc)
RHC-CGF-0510
36.4 kDa (predicted). Due to glycosylation, the pr
SCYA24, MPIF-2, MPIF2, member 24, Eotaxin-2, CK-+¦-6, CK-beta-6, Ckb-6, CCL24 CCL24 Protein, Mouse, Recombinant (His)
RHC-CGF-0418
11.7 kDa (predicted). Due to glycosylation, the pr
SCYA24, MPIF-2, MPIF2, member 24, Eotaxin-2, CK-+¦-6, CK-beta-6, Ckb-6, CCL24 CCL27 Protein, Human, Recombinant
RHC-CGF-0538
6-12 kDa (reducing condition)
Small-Inducible Cytokine A27, Skinkine, SCYA27, ILC, IL-11 R-+¦-Locus Chemokine, IL-11 R-Alpha-Locus Chemokine, Eskine, Cutaneous T-Cell-Attracting Chemokine, CTACK, CCL27, C-C Motif Chemokine 27, CC Chemokine ILC CCL27 Protein, Human, Recombinant (His)
RHC-CGF-0488
12.2 kDa (predicted); 14 kDa (reducing conditions)
SCYA27, PESKY, ILC, ESKINE, CTAK, CTACK, chemokine (C-C motif) ligand 27, CCL27, ALP CCL3 Protein, Human, Recombinant
RHC-CGF-0440
12 kDa (reducing condition)
Tonsillar Lymphocyte LD78 +¦, Tonsillar Lymphocyte LD78 Alpha Protein, Small-Inducible Cytokine A3, SIS-+¦, SIS-Beta, SCYA3, PAT 464.1, MIP-1-+¦, MIP-1-Alpha, MIP1A, Macrophage Inflammatory Protein 1-+¦, Macrophage Inflammatory Protein 1-Alpha, CCL3 Protein, Mouse, Recombinant (His)
RHC-CGF-0466
15 kDa (reducing condition)
Scya3, MIP1-a, MIP-1 +¦, MIP-1 alpha, Macrophage inflammatory protein 1-+¦, Macrophage inflammatory protein 1-alpha, LD78a, LD78 +¦, LD78 alpha, Heparin-binding chemotaxis protein, chemokine (C-C motif) ligand 3, C-C motif chemokine 3 CCL3L1 Protein, Human, Recombinant (His)
RHC-CGF-0537
16 kDa (reducing condition)
Tonsillar Lymphocyte LD78 +¦, Tonsillar Lymphocyte LD78 Beta Protein, Small-Inducible Cytokine A3-Like 1, SCYA3L1, PAT 464.2, LD78-+¦(1-70), LD78-Beta(1-70), G0S19-2, G0/G1 Switch Regulatory Protein 19-2, D17S1718, CCL3L3, CCL3L1, C-C Motif C CCL4 Protein, Human, Recombinant (His)
RHC-CGF-0412
9.2 kDa (predicted); 12-16 kDa (reducing condition
SCYA4, SCYA2, MIP-1-+¦, MIP-1-beta, MIP1B1, MIP1B, LAG-1, LAG1, HC21, G-26, chemokine (C-C motif) ligand 4, AT744.1, ACT2 CCL4 Protein, Mouse, Recombinant (His)
RHC-CGF-0461
11.8 kDa (predicted)
Small-inducible cytokine A4, SIS-gamma, Scya4, Protein H400, MIP-1-beta, Mip1b, Macrophage inflammatory protein 1-beta, Immune activation protein 2, Ccl4, C-C motif chemokine 4, ACT-2, ACT2 CCL5 Protein, Human, Recombinant
RHC-CGF-0534
8 kDa (predicted)
TCP228, SIS-+¦, SIS-delta, SISd, SCYA5, RANTES, eoCP, D17S136E, chemokine (C-C motif) ligand 5 CCL5 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0541
10.89 kDa (predicted) same as Tris-Bis PAGE result
TCP228, SIS-+¦, SIS-delta, SISd, SCYA5, RANTES, MuRantes, eoCP, D17S136E, CCL5 CCL5 Protein, Human, Recombinant (His & mucin)
RHC-CGF-0517
34 kDa (predicted); 50-80 kDa (reducing condition,
TCP228, SIS-+¦, SIS-delta, SISd, SCYA5, RANTES, eoCP, D17S136E, chemokine (C-C motif) ligand 5 CCL5 Protein, Mouse, Recombinant (hFc)
RHC-CGF-0420
35.2 kDa (predicted). Due to glycosylation, the pr
TCP228, SIS-+¦, SIS-delta, SISd, SCYA5, RANTES, MuRantes, eoCP, D17S136E, CCL5 CCL8 Protein, Human, Recombinant
RHC-CGF-0458
12 kDa (reducing condition)
Small-Inducible Cytokine A8, SCYA8, SCYA10, Monocyte Chemotactic Protein 2, Monocyte Chemoattractant Protein 2, MCP-2, MCP2, HC14, CCL8, C-C Motif Chemokine 8 CCL8 Protein, Human, Recombinant (His)
RHC-CGF-0568
13 kDa (reducing condition)
Small-Inducible Cytokine A8, SCYA8, SCYA10, Monocyte Chemotactic Protein 2, Monocyte Chemoattractant Protein 2, MCP-2, MCP2, HC14, CCL8, C-C Motif Chemokine 8 CCMP SODIUM SALT
CAS:54925-33-6
Trade Name: 3-[(4aR,6S,7S,7aS)-2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-y
Formula: C9H11N3NaO7P
ACM54925336
327.16
CCMP SODIUM SALT;CYTIDINE 3':5'-CYCLIC MONOPHOSPHATE SODIUM SALT;CYTIDINE-3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT;Cytidine, cyclic 3',5'-(hydrogen phosphate), monosodium salt;Cytidine-3'',5''-cyclic monophosphoric acid sodium salt;Cytidine 3 CCR6 Protein, Human, Recombinant (His & Myc)
RHC-RP-1306
12.9 kDa (predicted)
STRL22, LARC receptor, G-protein coupled receptor 29, GPR-CY4, GPRCY4, GPR29, DRY6, CMKBR6, CKR-L3, CKRL3, Chemokine receptor-like 3, CD196, CCR-6, CCR6, CC-CKR-6, C-C CKR-6, C-C chemokine receptor type 6 CCR8 Protein, Cynomolgus, Recombinant (mFc)
RHC-RP-1438
29.73 kDa (predicted). Due to glycosylation, the p
TER-1, TER1, GPR-CY6, GPRCY6, CY6, CMKBRL2, CMKBR8, CKR-L1, CKRL1, ChemR1, CDw198, CD198, CCR-8, CCR8 CCR8 Protein, Human, Recombinant (hFc)
RHC-RP-1269
30.62 kDa (predicted). Due to glycosylation, the p
TER-1, TER1, GPR-CY6, GPRCY6, CY6, CMKBRL2, CMKBR8, CKR-L1, CKRL1, ChemR1, CDw198, CD198, CCR-8, CCR8 CCR8 Protein, Human, Recombinant (mFc)
RHC-RP-1429
30.25 kDa (predicted). Due to glycosylation, the p
TER-1, TER1, GPR-CY6, GPRCY6, CY6, CMKBRL2, CMKBR8, CKR-L1, CKRL1, ChemR1, CDw198, CD198, CCR-8, CCR8 CCVJ
CAS:142978-18-5
Trade Name: (E)-3-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-yl)-2-cyanoprop-2-enoicacid
Formula: C16H16N2O2
ACM142978185-2
268.31
9-(2-Carboxy-2-cyanovinyl)julolidine,(2E)-2-Cyano-3-(2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)acrylicacid CCVJ
CAS:142978-18-5
Trade Name: (E)-3-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-yl)-2-cyanoprop-2-enoicacid
Formula: C16H16N2O2
ACM142978185-2
268.31
9-(2-Carboxy-2-cyanovinyl)julolidine,(2E)-2-Cyano-3-(2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)acrylicacid CD117 Protein, Human, Recombinant (hFc)
RHC-CD-0181
100-140 kDa (reducing condition)
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, Tyrosine-protein kinase Kit, SCFR, Proto-oncogene c-Kit, Piebald trait protein, PBT, p145 c-kit, Mast/stem cell growth factor receptor Kit, KIT, CD117 CD117 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0303
58.60 kDa (predicted). Due to glycosylation, the p
SCFR, PBT, KIT, EC 2.7.10.1, EC 2.7.10, c-kit, ckit, CD117 CD122/IL2RB Protein (Primary Amine Labeling), Cynomolgus, Recombinant (His), Biotinylated
RHC-CD-2663
25.6 kDa (predicted). Due to glycosylation, the pr
RP5-1170K4.6, p75, P70-75, IL2RB, IL-2R subunit +¦, IL-2R subunit beta, IL-2 R +¦/CD122, IL-2 R +¦, IL-2 R beta, IL-15 R +¦, IL-15 R beta, CD122 CD122/IL2RB Protein, Human, Recombinant
RHC-CD-0356
25.2 kDa (predicted); 40 kDa (reducing condition,
P70-75, interleukin 2 receptor, +¦, interleukin 2 receptor, beta, IL-15RB, IL15RB, CD122 CD122/IL2RB Protein, Human, Recombinant (aa 27-239, His & Avi), Biotinylated
RHC-CD-2572
35-45 kDa (reducing condition)
Interleukin-2 receptor subunit +¦, Interleukin-2 receptor subunit beta, IL2RB, IL-2R subunit +¦, IL-2R subunit beta, IL-2 receptor subunit +¦, IL-2 receptor subunit beta, High affinity IL-2 receptor subunit +¦, High affinity IL-2 receptor subun |
